Skip to main content
. 2024 Aug 19;8(10):bvae143. doi: 10.1210/jendso/bvae143

Table 2.

Metabolic characteristics of patients in MetS group and control group

MetS group Control group P value
(n = 1147) (n = 7392)
BMI ≥ 25 kg/m2 (%) 1036/1147 (90.3) 1453/7392 (19.7) <.001
TG ≥ 1.70 mmol/L (%) 634/1147 (55.3) 314/7392 (4.2) <.001
HDL-C ≤ 1.29 mmol/L (%) 1061/1147 (92.5) 2879/7392 (38.9) <.001
BP ≥ 130/85 mmHg (%) 438/1147 (38.2) 512/7392 (6.9) <.001
FPG ≥ 5.6 mmol/L (%) 629/1147 (54.8) 950/7392 (12.9) <.001
BMI (kg/m2) 27.53 (26.01-29.50) 22.30 (20.49-24.44) <.001
Blood lipid levels
 Total cholesterol (mmol/L) 4.49 (3.94-5.03) 4.18 (3.72-4.70) <.001
 TG (mmol/L) 1.77 (1.14-2.25) 0.81 (0.62-1.00) <.001
 HDL-C (mmol/L) 1.08 (0.95-1.21) 1.37 (1.19-1.56) <.001
 LDL-C (mmol/L) 2.87 (2.41-3.28) 2.53 (2.17-2.94) <.001
Blood pressure (mmHg)
 Systolic 122.21 (112.97-131.74) 111.05 (103.44-119.29) <.001
 Diastolic 73.10 (66.67-80.44) 66.01 (60.41-71.87) <.001
Fasting plasma glucose (mmol/L) 5.63 (5.23-5.83) 5.16 (4.91-5.42) <.001

Results are expressed as median (25-75%) or n (%).

Abbreviations: BMI, body mass index; BP, blood pressure; FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MetS, metabolic syndrome; TG, triglycerides.